Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.
暂无分享,去创建一个
M. Levrero | G. Raimondo | F. Guerrieri | T. Pollicino | V. Schinzari | M. Cervello | G. Montalto | N. Pediconi | R. De Iaco | S. Vossio | C. Scisciani | Paolo D'Onorio de Meo
[1] I. Ng,et al. MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B 2 , 2010, Hepatology.
[2] Derek Y. Chiang,et al. Cancer gene discovery in hepatocellular carcinoma. , 2010, Journal of hepatology.
[3] I. Ng,et al. RhoGTPases and Rho‐effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[4] Ming Yao,et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA , 2010, Nature Cell Biology.
[5] Ming Yao,et al. MicroRNA‐30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma , 2010, Hepatology.
[6] Ji Wan,et al. Structure and activity of putative intronic miRNA promoters. , 2010, RNA.
[7] J. Llovet,et al. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. , 2010, Seminars in liver disease.
[8] Zhimin Zhang,et al. MicroRNA‐224 is upregulated in HepG2 cells and involved in cellular migration and invasion , 2010, Journal of gastroenterology and hepatology.
[9] S. Lowe,et al. miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.
[10] C. Croce,et al. MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Ghoshal,et al. TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.
[12] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[13] M. Kurrer,et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. , 2009, Cancer cell.
[14] J. Llovet,et al. Lymphotoxins: new targets for hepatocellular carcinoma. , 2009, Cancer cell.
[15] K. Ghoshal,et al. MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib* , 2009, The Journal of Biological Chemistry.
[16] Derek Y. Chiang,et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.
[17] Shuhan Sun,et al. Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.
[18] S. Saad,et al. ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration. , 2009, Biochimica et biophysica acta.
[19] Hsien-Da Huang,et al. MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.
[20] V. Moreau,et al. Rho GTPases in hepatocellular carcinoma. , 2009, Biochimica et biophysica acta.
[21] M. Karin,et al. NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.
[22] C. Croce,et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma , 2008, Oncogene.
[23] Anne J. Ridley,et al. Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.
[24] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[25] Kuo-Bin Li,et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.
[26] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[27] A. Elsharkawy,et al. Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis , 2007 .
[28] C. Croce,et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.
[29] Frank Staib,et al. Genetics of hepatocellular carcinoma. , 2007, World journal of gastroenterology.
[30] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[31] J. Tcherkezian,et al. Current knowledge of the large RhoGAP family of proteins , 2007, Biology of the cell.
[32] S. Boyault,et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.
[33] K. Ghoshal,et al. Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas , 2006, Journal of cellular biochemistry.
[34] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[35] J. Bruix,et al. Management of hepatocellular carcinoma , 2005, Hepatology.
[36] H. Blum,et al. Pathogenesis of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.
[37] Francesco Donato,et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.
[38] M. Fabbri,et al. Epigenetics and miRNAs in human cancer. , 2010, Advances in genetics.
[39] A. Elsharkawy,et al. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. , 2007, Hepatology.
[40] V. Mazzaferro,et al. Resection and Liver Transplantation for Hepatocellular Carcinoma , 2005, Seminars in liver disease.
[41] G. Blandino,et al. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. , 2002, Molecular cell.